SERPINC1 and inflammatory bowel disease: The search for common thrombophilic markers in IBD has, however, revealed conflicting results.[5–7] Low levels of natural coagulation inhibitors such as antithrombin III (AT-III) and proteins C and S have been observed in some patients with IBD[8, 9] but not in the entire population.[10, 11]